[1] Dubosar R. Are ONTT recommendations understood[J] ?Ocular surgery News International Edition, 2000, 11(3): 48. [2] Trobe JD,Sieving PC,Guire KE. et al. The impact of the optic nerve neuritis treatment trial on the opthalmologists and neurologists[J].Opthalmology, 1999,106(11):2047-2053. [3] 周婉瑜,刘勤,张美芬,等.急性视神经炎的糖皮质激素治疗[J].眼科研究, 2000, 18(1):51-53. [4] Wu W, Liu K,Tang X. Preliminary study on the antitumor immuno-protective mechanism of b-elemene[J]. Zhong-hua Zhong Liu Za Zhi,1999, 21(6): 405-408. [5] 许洪升, 黎军, 刘军, 等. 榄香烯对脑肿瘤患者血清SOD活性影响的研究[J].中国肿瘤临床, 1996, 23(7):79. [6] 陆群, 谢梅林, 朱路佳,等. 榄香烯乳抑制大鼠血小板聚集的机理研究[J].苏州医学院学报, 1996, 16(5): 844-846. [7] Kuertena S, Kostova-Balesa DA, Frenzel LP, et al. MP4- and MOG:35-55- induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum[J]. J Neuroimmunol, 2007, 189(1/2):30-40. [8] Beck RW, Trobe JD, Moke PS et al. High-and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis:experience of the optic neuritis treatment trial[J]. Arch Ophthalmol, 2003, 121(7): 944-949. [9] Kang PS, Munter FM, Swallow C, et al. Optic neuritis. eMedicine. February 8, 2006. http://www.emedicine.medscape.com/article/383642-review. [10] Cohen MM, Lessell S, Wolf PA. A prospective study of therisk of developing multiple sclerosis in uncomplicated optic neuritis[J]. Neurology, 1979, 29(2): 208-213. [11] Rizzo JF, Lessell S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: A long-term prospective study[J].Neurology, 1988, 38(2): 185-190. [12] Kanski JJ. Clinical ophthalmology 14th ed[J].Oxford Butterworth-Heinerann, 2000:590-593. [13] Sellebjerg F, Nielsen HS, Frederiksen JL, et al.A randomized controlled trial of oral high-dose methyl prednisolone in acute optic neuritis[J].Neurology, 1999, 52(7):1479-1484. [14] 陈贻言.泼尼松龙联合施善治疗急性视神经炎疗效观察[J].国际眼科杂志, 2004, 4(3):576-577. [15] 景筠.视神经炎与多发性硬化的视神经功能障碍[J].中国神经免疫学和神经病学杂志, 2001, 8(4):211-214. [16] Beck RW,Gal RL,Bhatti MT, et al. Visual function more than 10 years after optic neuritis:experience of the optic neuritis treatment trial[J]. Am J Ophthalmol, 2004, 137(1):77-83. [17] Mendel I, Kerlero de Rosbo N, Ben-Nun A. A myelin oligodendroeyte glyeoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine spceificity and T cell receptor V expression of encephalitogenic T cells[J].Eur J Immunol, 1995, 25(7): 1951-1959. |